Task: Answer the MCQ question.
Question: Which drug exhibits a -13.724% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) O=C1c2ccccc2NC(c2ccccc2Br)N1CCCN1CCOCC1
b.) C=CCOc1ccc(CNc2ccc3[nH]c(=O)[nH]c3c2)cc1
c.) COc1ccccc1-n1cnc2cc(C(=O)NCC3CCCO3)ccc21
Answer: c. COc1ccccc1-n1cnc2cc(C(=O)NCC3CCCO3)ccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccccc1-n1cnc2cc(C(=O)NCC3CCCO3)ccc21
COc1ccccc1-n1cnc2cc(C(=O)NCC3CCCO3)ccc21
1-(2-methoxyphenyl)-N-(oxolan-2-ylmethyl)benzimidazole-5-carboxamide